Shariat, Shahrokh

Publications

Sort by

Co-Author Network

selected publications

ASO Visual Abstract: The Effect of Pelvic Lymph Node Dissection on Cancer-Specific Mortality in Partial Cystectomy According to Eligibility Criteria. Annals of surgical oncology. 2026 Academic Article GET IT
ASO Visual Abstract: Type 2 Diabetes Mellitus Versus Adverse In-Hospital Outcomes After Partial or Radical Nephrectomy. Annals of surgical oncology. 2026 Academic Article GET IT
Clinical complete response as a surrogate for pathological response in bladder cancer: a systematic review and meta-analysis. BJU international. 2026 Review GET IT
ASO Author Reflections: Type 2 Diabetes Mellitus and Insulin-Dependence as Determinants of Adverse In-Hospital Outcomes After Partial or Radical Nephrectomy. Annals of surgical oncology. 2026 Academic Article GET IT
Response to comments on 'Adverse in-hospital outcomes in patients with paraplegia who undergo radical prostatectomy'. BJU international. 2026 Letter GET IT
Type 2 Diabetes Mellitus Versus Adverse In-Hospital Outcomes After Partial or Radical Nephrectomy. Annals of surgical oncology. 2026 Academic Article GET IT
Perioperative Immune Checkpoint Inhibitors Combined with Radical Cystectomy: A Rapid Systematic Review and Meta-analysis. European urology open science. 2026 Review GET IT
Incremental dose-response effect of age on mortality in non-seminoma testis cancer patients. Urologic oncology. 2026 Academic Article GET IT
ABCG2-mediated SN-38 efflux drives resistance to Sacituzumab govitecan in urothelial carcinoma. Cancer letters. 2026 Academic Article GET IT
Efficacy and safety of active surveillance and chemoablation in the management of non-muscle invasive bladder cancer (NMIBC): Systematic review and pooled analysis by the European Association of Urology-Young Academic Urologists: Urothelial Carcinoma Working Group. Actas urologicas espanolas. 2026 Review GET IT
The Effect of Pelvic Lymph Node Dissection on Cancer-Specific Mortality in Partial Cystectomy According to Eligibility Criteria. Annals of surgical oncology. 2025 Academic Article GET IT
Intraoperative assessment of surgical margins during radical prostatectomy: advances and challenges. Current opinion in urology. 2025 Review GET IT
Cannabis use and risk of testicular germ cell tumour: a systematic review and meta-analysis. BJU international. 2025 Review GET IT
Enfortumab vedotin plus pembrolizumab in treatment-naïve metastatic urothelial carcinoma patients: An Austrian real-world analysis. International journal of cancer. 2025 Academic Article GET IT
Diagnostic efficacy of serum microRNAs in predicting pathology of retroperitoneal lymph node dissection in patients with testicular germ cell tumors: a systematic review and meta-analysis. World journal of urology. 2025 Review GET IT
Effect of Race/Ethnicity on In-hospital Outcomes After Radical Cystectomy. Journal of racial and ethnic health disparities. 2025 Academic Article GET IT
Times cited: 5
Non-Caucasian Race/Ethnicity Predisposes to Unfavorable Stage and Grade at Upper Tract Urothelial Carcinoma Diagnosis. Journal of racial and ethnic health disparities. 2025 Academic Article GET IT
Times cited: 2
Preoperative Plasma Insulin-Like Growth Factor-I and Its Binding Proteins-Based Risk Stratification of Patients Treated With Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma. Clinical genitourinary cancer. 2024 Academic Article GET IT
Primary retroperitoneal lymph node dissection for clinical stage II seminoma: A systematic review and meta-analysis of safety and oncological effectiveness. Urologic oncology. 2024 Review GET IT
Times cited: 6
Treatment Patterns and Real-World Outcomes for Locally Advanced or Metastatic Urothelial Cancer in the Era of Immunotherapy. European urology focus. 2023 Academic Article GET IT
Times cited: 3
Metastatic Organotropism Differential Treatment Response in Urothelial Carcinoma: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials. European urology oncology. 2023 Academic Article GET IT
Times cited: 2
Cytoreductive Surgery in Patients with Urothelial Bladder Cancer. European urology focus. 2022 Academic Article GET IT
Times cited: 1
A Systematic Review and Meta-Analysis of Clinicopathologic Factors Predicting Upper Urinary Tract Recurrence After Radical Cystectomy for Urothelial Bladder Cancer. Clinical genitourinary cancer. 2022 Review GET IT
Times cited: 2
Re: Lymph Node Colonization Induces Tumor-immune Tolerance To Promote Distant Metastasis. European urology. 2022 Academic Article GET IT
Times cited: 2
Association of age with response to preoperative chemotherapy in patients with muscle-invasive bladder cancer. World journal of urology. 2021 Academic Article GET IT
Times cited: 6
Placebo Response in Patients with Oral Therapy for Overactive Bladder: A Systematic Review and Meta-analysis. European urology focus. 2021 Review GET IT
Times cited: 14
Fibroblast growth factor receptor: A systematic review and meta-analysis of prognostic value and therapeutic options in patients with urothelial bladder carcinoma. Urologic oncology. 2021 Review GET IT
Times cited: 23
Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial. European urology. 2020 Comment GET IT
Times cited: 1
The Performance of Tumor Size as Risk Stratification Parameter in Upper Tract Urothelial Carcinoma (UTUC). Clinical genitourinary cancer. 2020 Academic Article GET IT
Times cited: 20
The value and limitations of urothelial bladder carcinoma molecular classifications to predict oncological outcomes and cancer treatment response: A systematic review and meta-analysis. Urologic oncology. 2020 Review GET IT
Times cited: 9
Impact of sex on response to neoadjuvant chemotherapy in patients with bladder cancer. Urologic oncology. 2020 Academic Article GET IT
Times cited: 15
Impact of Patients' Gender on Efficacy of Immunotherapy in Patients With Metastatic Kidney Cancer: A Systematic Review and Meta-analysis. Clinical genitourinary cancer. 2019 Review GET IT
Times cited: 22
Re: Enzalutamide with Standard First-line Therapy in Metastatic Prostate Cancer. European urology. 2019 Comment GET IT
Do Younger Patients with Muscle-Invasive Bladder Cancer have Better Outcomes?. Journal of clinical medicine. 2019 Academic Article GET IT
Times cited: 16
Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis. World journal of urology. 2019 Review GET IT
Times cited: 31
Oncological safety of testosterone replacement therapy in prostate cancer survivors after definitive local therapy: A systematic literature review and meta-analysis. Urologic oncology. 2019 Review GET IT
Times cited: 29
Prevalence and Prognostic Value of the Polymorphic Variant 1245A>C of HSD3B1 in Castration-resistant Prostate Cancer. Clinical genitourinary cancer. 2019 Academic Article GET IT
Times cited: 6
Association of an organ transplant-based approach with a dramatic reduction in postoperative complications following radical nephrectomy and tumor thrombectomy in renal cell carcinoma. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2019 Academic Article GET IT
Times cited: 18
Focal Neuroendocrine Differentiation of Conventional Prostate Adenocarcinoma as a Prognostic Factor after Radical Prostatectomy: A Systematic Review and Meta-Analysis. International journal of molecular sciences. 2019 Review GET IT
Times cited: 9
Micropapillary Urothelial Carcinoma of the Bladder: A Systematic Review and Meta-analysis of Disease Characteristics and Treatment Outcomes. European urology. 2018 Review GET IT
Times cited: 86
Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy. Urologic oncology. 2018 Academic Article GET IT
Times cited: 12
Development and external validation of a pathological nodal staging score for patients with clear cell renal cell carcinoma. World journal of urology. 2018 Academic Article GET IT
Times cited: 3
The effect of androgen deprivation treatment on subsequent risk of bladder cancer diagnosis in male patients treated for prostate cancer. World journal of urology. 2018 Academic Article GET IT
Times cited: 15
Re: Docetaxel Versus Surveillance After Radical Prostatectomy for High-risk Prostate Cancer: Results from the Prospective Randomised, Open-label Phase 3 Scandinavian Prostate Cancer Group 12 Trial. European urology. 2018 Comment GET IT
Predictors of Cancer-specific Survival After Disease Recurrence in Patients With Renal Cell Carcinoma: The Effect of Time to Recurrence. Clinical genitourinary cancer. 2018 Academic Article GET IT
Times cited: 17
Accurate prediction of progression to muscle-invasive disease in patients with pT1G3 bladder cancer: A clinical decision-making tool. Urologic oncology. 2018 Academic Article GET IT
Times cited: 32
Impact of age on outcomes of patients with non-muscle-invasive bladder cancer treated with immediate postoperative instillation of mitomycin C. Urologic oncology. 2017 Academic Article GET IT
Times cited: 7
Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder. World journal of urology. 2017 Academic Article GET IT
Times cited: 37
ABO Blood Group and Rhesus Factor Are Not Associated with Outcomes After Radical Cystectomy for Non-metastatic Urothelial Carcinoma of the Bladder. Anticancer research. 2017 Academic Article GET IT
Times cited: 7
Re: Adjuvant Chemotherapy vs Observation for Patients with Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy. European urology. 2017 Comment GET IT
Times cited: 1
Comparison of the EORTC tables and the EAU categories for risk stratification of patients with nonmuscle-invasive bladder cancer. Urologic oncology. 2017 Academic Article GET IT
Times cited: 45
Frequency and prognostic significance of incidental prostate cancer at radical cystectomy: Results from an international retrospective study. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2017 Academic Article GET IT
Times cited: 13
External Validation of the Pathologic Nodal Staging Score for Prostate Cancer: A Population-based Study. Clinical genitourinary cancer. 2017 Academic Article GET IT
Times cited: 1
Prognostic Role of N-cadherin Expression in Patients With Invasive Bladder Cancer. Clinical genitourinary cancer. 2017 Academic Article GET IT
Times cited: 10
Frequency and Prognostic Value of PTEN Loss in Patients with Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy. The Journal of urology. 2017 Academic Article GET IT
Times cited: 5
Re: Radiation with or Without Antiandrogen Therapy in Recurrent Prostate Cancer. European urology. 2017 Comment GET IT
Re: Comparative Effectiveness of Treatment Strategies for Bladder Cancer with Clinical Evidence of Regional Lymph Node Involvement. European urology. 2017 Comment GET IT
Times cited: 1
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Primary Non-muscle-invasive Bladder Cancer. Clinical genitourinary cancer. 2017 Academic Article GET IT
Times cited: 39
Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy. World journal of urology. 2017 Academic Article GET IT
Times cited: 40
Electronic Cigarettes: A Wolf in Sheep's Clothing. European urology. 2017 Editorial Article GET IT
Times cited: 2
Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study. World journal of urology. 2016 Academic Article GET IT
Times cited: 8
External validation of the pathological nodal staging score in upper tract urothelial carcinoma: A population-based study. Urologic oncology. 2016 Academic Article GET IT
Times cited: 15
Prognostic significance of markers of systemic inflammatory response in patients with non-muscle-invasive bladder cancer. Urologic oncology. 2016 Academic Article GET IT
Times cited: 67
Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy. Clinical genitourinary cancer. 2016 Academic Article GET IT
Times cited: 39
Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study. World journal of urology. 2016 Academic Article GET IT
Times cited: 29
Re: Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations. European urology. 2016 Comment GET IT
Times cited: 1
Current Status of Urinary Biomarkers for Detection and Surveillance of Bladder Cancer. The Urologic clinics of North America. 2016 Review GET IT
Times cited: 72
Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent. World journal of urology. 2015 Academic Article GET IT
Times cited: 4
Adrenal Lesions: Progress on All Fronts. European urology focus. 2015 Editorial Article GET IT
ERCC1 as a Prognostic and Predictive Biomarker for Urothelial Carcinoma of the Bladder following Radical Cystectomy. The Journal of urology. 2015 Academic Article GET IT
Times cited: 26
Association of Cigarette Smoking and Smoking Cessation with Biochemical Recurrence of Prostate Cancer in Patients Treated with Radical Prostatectomy. European urology. 2015 Academic Article GET IT
Times cited: 45
The Neutrophil-to-lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy: Validation and Meta-analysis. European urology focus. 2015 Academic Article GET IT
Times cited: 42
Prognostic Model for Predicting Survival in Patients with Disease Recurrence Following Radical Cystectomy. European urology focus. 2015 Academic Article GET IT
Times cited: 7
There Are Cooler Ways to Die Than Smoking: Urologists of the World, Unite Against This Health Care Tragedy. European urology focus. 2015 Editorial Article GET IT
Times cited: 1
Novel biomarkers to predict response and prognosis in localized bladder cancer. The Urologic clinics of North America. 2015 Review GET IT
Times cited: 9
Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature. European urology. 2015 Information Resource GET IT
Times cited: 168
Corrigendum to "Characteristics and Outcomes of Patients with Clinical T1 Grade 3 Urothelial Carcinoma Treated with Radical Cystectomy: Results from an International Cohort" [Eur Urol 2010;57:300-9]. 2015 GET IT
Times cited: 1
Prostate cancer risk estimation tool use by members of the American Urological Association: a survey based study. The Journal of urology. 2015 Academic Article GET IT
Times cited: 4
Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic model. Urologic oncology. 2014 Academic Article GET IT
Times cited: 24
Words of wisdom. Re: radical prostatectomy or watchful waiting in early prostate cancer. European urology. 2014 Comment GET IT
Times cited: 1
Predictors of cancer-specific mortality after disease recurrence in patients with squamous cell carcinoma of the penis. European urology. 2014 Comment GET IT
Times cited: 12
Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2014 Academic Article GET IT
Times cited: 15
Incorporating biomarker research in a real-world setting: challenges of a prophecy. Urologic oncology. 2014 Article GET IT
Times cited: 1
Optimal results come from optimal surgery and optimal (neoadjuvant) systemic therapy. BJU international. 2014 Editorial Article GET IT
Times cited: 1
Utility and limitations of 3-Tesla diffusion-weighted magnetic resonance imaging for differentiation of renal tumors. European journal of radiology. 2014 Academic Article GET IT
Times cited: 47
Effect of ABO blood type on mortality in patients with urothelial carcinoma of the bladder treated with radical cystectomy. Urologic oncology. 2014 Academic Article GET IT
Times cited: 26
Combining smoking information and molecular markers improves prognostication in patients with urothelial carcinoma of the bladder. Urologic oncology. 2014 Academic Article GET IT
Times cited: 24
Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma. European urology. 2013 Academic Article GET IT
Times cited: 24
Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder. Urologic oncology. 2013 Review GET IT
Times cited: 31
Impact of ABO blood type on outcomes in patients with primary nonmuscle invasive bladder cancer. The Journal of urology. 2013 Academic Article GET IT
Times cited: 18
Gender-specific differences in clinicopathologic outcomes following radical cystectomy: an international multi-institutional study of more than 8000 patients. European urology. 2013 Academic Article GET IT
Times cited: 104
Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma. Urologic oncology. 2013 Academic Article GET IT
Times cited: 27
Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2013 Academic Article GET IT
Times cited: 22
Prediction of intravesical recurrence after radical nephroureterectomy: development of a clinical decision-making tool. European urology. 2013 Academic Article GET IT
Times cited: 154
Association of T-cell co-regulatory protein expression with clinical outcomes following radical cystectomy for urothelial carcinoma of the bladder. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2013 Academic Article GET IT
Times cited: 140
Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy?. Urologic oncology. 2013 Academic Article GET IT
Times cited: 6
Urine markers for detection and surveillance of bladder cancer. Urologic oncology. 2013 Review GET IT
Times cited: 95
Association of oncofetal protein expression with clinical outcomes in patients with urothelial carcinoma of the bladder. The Journal of urology. 2013 Academic Article GET IT
Times cited: 17
Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool. European urology. 2013 Academic Article GET IT
Times cited: 20
Effect of statin use on outcomes of non-muscle-invasive bladder cancer. BJU international. 2013 Academic Article GET IT
Times cited: 22
Accurate risk assessment of patients with asymptomatic hematuria for the presence of bladder cancer. World journal of urology. 2012 Academic Article GET IT
Times cited: 33
Pathologic nodal staging score for bladder cancer: a decision tool for adjuvant therapy after radical cystectomy. European urology. 2012 Academic Article GET IT
Times cited: 33
Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification. European urology. 2012 Academic Article GET IT
Times cited: 30
Risk stratification of organ confined bladder cancer after radical cystectomy using cell cycle related biomarkers. The Journal of urology. 2011 Academic Article GET IT
Times cited: 35
Clinical nodal staging scores for bladder cancer: a proposal for preoperative risk assessment. European urology. 2011 Academic Article GET IT
Times cited: 52
Emerging biomarkers for prostate cancer diagnosis, staging, and prognosis. Archivos espanoles de urologia. 2011 Review GET IT
Times cited: 21
Assessing the clinical benefit of nuclear matrix protein 22 in the surveillance of patients with nonmuscle-invasive bladder cancer and negative cytology: a decision-curve analysis. Cancer. 2011 Academic Article GET IT
Times cited: 51
Gender differences in radical nephroureterectomy for upper tract urothelial carcinoma. World journal of urology. 2010 Academic Article GET IT
Times cited: 144
Tissue-based molecular markers for bladder cancer. Minerva urologica e nefrologica = The Italian journal of urology and nephrology. 2010 Review GET IT
Times cited: 10
Update on intravesical agents for non-muscle-invasive bladder cancer. Immunotherapy. 2010 Review GET IT
Times cited: 21
Association of angiogenesis related markers with bladder cancer outcomes and other molecular markers. The Journal of urology. 2010 Academic Article GET IT
Times cited: 93
International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy. BJU international. 2010 Academic Article GET IT
Times cited: 136
Statistical consideration for clinical biomarker research in bladder cancer. Urologic oncology. 2010 Review GET IT
Times cited: 134
Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study. Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Academic Article GET IT
Times cited: 62
p53 expression in patients with advanced urothelial cancer of the urinary bladder. BJU international. 2009 Academic Article GET IT
Times cited: 64
p53 predictive value for pT1-2 N0 disease at radical cystectomy. The Journal of urology. 2009 Academic Article GET IT
Times cited: 53
Predictive value of combined immunohistochemical markers in patients with pT1 urothelial carcinoma at radical cystectomy. The Journal of urology. 2009 Academic Article GET IT
Times cited: 82
Words of wisdom. Re: Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma. Hudes G, Carducci M, Tomczak P, Dutcher J, Figlin R, Kapoor A, Staroslawska E, Sosman J, McDermott D, Bodrogi I, Kovacevic Z, Lesovoy V, Schmidt-Wolf IG, Barbarash O, Gokmen E, O'Toole T, Lustgarten S, Moore L, Motzer RJ; Global ARCC Trial. N Engl J Med 2007;356:2271-81. European urology. 2009 Comment GET IT
Words of wisdom. Re: Timing of androgen deprivation therapy and its impact on survival after radical prostatectomy: a matched cohort study. Siddiqui SA, Boorjian SA, Inman B, Bagniewski S, Bergstralh EJ, Blute ML. J Urol 2008;179:1830-7; discussion 1837. European urology. 2009 Comment GET IT
An updated catalog of prostate cancer predictive tools. Cancer. 2008 Review GET IT
Times cited: 236
Can nomograms be superior to other prediction tools?. BJU international. 2008 Academic Article GET IT
Times cited: 2

more ...

less ...

Background

education and training

M.D., University of Vienna Faculty of Medicine (Austria) 1998

Contact

full name

Shahrokh Shariat

primary email

sfs2002@med.cornell.edu

VIVO Weill Cornell Medical College

Shahrokh Shariat Adjunct Clinical Associate Professor of Urology

Publications

selected publications

Background

education and training

Contact

full name

primary email